MONITORING ANTI-ANGIOGENESIS THERAPY

摘要

The present invention relates to a method for monitoring subjects being on anti-angiogenesis therapy based on determining the amount of a cardiac Troponin in a first and second sample of a subject and comparing the amount in said first sample with said second sample. Thereby, it can be assessed whether a subject is susceptible to a continuation of said therapy or not. Moreover, the present invention relates to a method for predicting the risk of a cardiovascular event as a consequence of anti-angiogenesis therapy. Also encompassed by the present invention are kits and devices adapted to carry out the method of the present invention.